All treatments
Treatment
Cannabis Extract Avextra 10/10 Solution clinical trials
3 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
Cannabis extrAct in oncology Patients for the treatment of TUmor Related symptom burden (CAPTURE)
This study looks into whether a cannabis-based medicine could help reduce symptoms in cancer patients who are already taking strong pain relief. It compares the cannabis medicine to a similar-looking dummy medicine.
For: Patients with advanced oncologic disease receiving active treatment with WHO level II or III opioids and adjuvants therapiesItaly - AuthorisedTherapeutic exploratory (Phase II)
MEDICAL CANNABIS FOR NEURODEGENERATIVE DISEASES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL (NEUROBIS)
This study looks at how a cannabis-based medicine, Avextra 10/10, might help people with Alzheimer's, Parkinson's, or ALS. Researchers want to see if it improves their quality of life and if it's safe to use, compared to a dummy treatment.
For: Patients suffering from neurodegenerative diseases: Amyotrophic Lateral Sclerosis (ALS) · Alzheimer’s Disease (AD) and Parkinson’s Disease (PD).Italy - Ongoing, recruitingTherapeutic exploratory (Phase II)
Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BELCANTO)
This study is testing if cannabis extract can improve the quality of life for cancer patients receiving palliative care. It compares the cannabis extract to a placebo to see if it helps with symptoms and overall well-being over approximately 12 days.
For: oncology · palliative care · quality of lifeGermany